Humana Inc. $HUM Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC grew its holdings in shares of Humana Inc. (NYSE:HUM) by 38.7% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 956,743 shares of the insurance provider’s stock after purchasing an additional 267,139 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Humana were worth $236,095,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Humana by 16.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock worth $300,728,000 after buying an additional 158,528 shares during the period. Focus Partners Wealth lifted its position in Humana by 104.2% during the 1st quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after acquiring an additional 3,281 shares in the last quarter. Swedbank AB boosted its holdings in Humana by 5.3% in the 2nd quarter. Swedbank AB now owns 100,397 shares of the insurance provider’s stock worth $24,545,000 after acquiring an additional 5,032 shares during the period. Kera Capital Partners Inc. purchased a new position in Humana in the 2nd quarter worth approximately $253,000. Finally, Bank of Nova Scotia grew its position in Humana by 219.3% in the second quarter. Bank of Nova Scotia now owns 242,385 shares of the insurance provider’s stock valued at $59,258,000 after acquiring an additional 166,475 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on HUM shares. Jefferies Financial Group raised shares of Humana from a “hold” rating to a “buy” rating and boosted their target price for the stock from $253.00 to $313.00 in a research report on Friday, December 5th. KeyCorp reaffirmed a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Barclays decreased their price objective on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 25th. Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Finally, Sanford C. Bernstein boosted their price target on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Nine investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $294.32.

Humana Stock Up 0.3%

HUM stock opened at $259.12 on Wednesday. The firm has a market cap of $31.16 billion, a price-to-earnings ratio of 24.28, a PEG ratio of 1.51 and a beta of 0.46. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The firm has a fifty day moving average price of $257.35 and a two-hundred day moving average price of $260.91. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. During the same period in the previous year, the business posted $4.16 EPS. The company’s quarterly revenue was up 11.1% on a year-over-year basis. Research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.